The Coronavirus Impact Scale Validity and Reliability Study
October 14, 2022 updated by: Hacer Gok Ugur, T.C. ORDU ÜNİVERSİTESİ
Turkish Validity and Reliability Study of The Coronavirus Impact Scale
This research; The Turkish validity and reliability study of the "Coronavirus Impact Scale" developed by Stoddard and Kaufman (2020) will be conducted in order to bring a new measurement tool to our country.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This research; The Turkish validity and reliability study of the "Coronavirus Impact Scale" developed by Stoddard and Kaufman (2020) will be conducted in order to bring a new measurement tool to our country.
Method: This research was planned as a methodological study. Research Question: Is the "Coronavirus Impact Scale" a valid and reliable measurement tool for Turkish society?
Study Type
Observational
Enrollment (Actual)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cumhurıyet Campus
-
Ordu, Cumhurıyet Campus, Turkey, 52000
- Ordu Univercity
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adults presenting to outpatient clinics in the hospital.
Description
Inclusion Criteria:
- At least 18 years old,
- At least primary school graduate,
- Able to communicate verbally and
- Persons who agree to participate in the research will be included in the research.
Exclusion Criteria:
- Psychiatric illness and unable to communicate,
- Having a language problem
- Persons who do not have the skills to read and understand the questionnaire will be excluded from the research.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Coronavirus Impact Scale
Time Frame: 8 months
|
The Coronovirus Impact Scale was developed by Stoddard and Kaufman (2020) to assess the impact of Covid-19 on people.
The scale consists of 12 questions.
Questions 1-9 in the scale are in 4-point Likert type, 0. There is no change, 1. Mild, 2. Moderate and 3. Severe, and points are taken between 0-3 from these questions.
The questions between 10 and 11 on the scale are in a 5-point Likert type and are scored between 0-4 (indicating that from mild symptoms to death).
However, the number of first degree family members diagnosed with coronavirus in question 10 and the number of relatives or close friends diagnosed with coronavirus in question 11 are not taken into account in the scale.
The 12th question of the scale is open-ended and determines the other aspects that the coronavirus epidemic affects life.
A minimum score of 0 and a maximum score of 35 are obtained from the scale, and as the score increases, the degree of exposure of people to the Corona virus increases.
|
8 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2021
Primary Completion (Actual)
January 1, 2022
Study Completion (Actual)
March 21, 2022
Study Registration Dates
First Submitted
August 16, 2021
First Submitted That Met QC Criteria
August 16, 2021
First Posted (Actual)
August 24, 2021
Study Record Updates
Last Update Posted (Actual)
October 18, 2022
Last Update Submitted That Met QC Criteria
October 14, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ayyuzlum3207*
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.